Bora Pharmaceuticals (6472.TW) Earnings Analysis

Bora Pharmaceuticals (6472.TW) next reports earnings on 2026-08-18, consensus EPS 5.05 TWD. Last quarter (2026-03-11) it missed with EPS 2.65 TWD vs 7.49 TWD est (-64.6%). It has beaten estimates in 0/4 recent quarters (0%). Trailing P/E 31.18.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 6472.TW next report earnings?

Next earnings date2026-08-18
Consensus EPS estimate5.05 TWD
Revenue estimate5.48B

6472.TW earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-112.65 TWD7.49 TWD-64.6%Miss
2025-11-134.99 TWD9.27 TWD-46.2%Miss
2025-05-1412.74 TWD25.56 TWD-50.2%Miss
2025-03-055.82 TWD9.61 TWD-39.4%Miss

Beat rate: 0/4 (0%) over reported quarters with consensus data.

6472.TW valuation and analyst view

Trailing P/E31.18
Trailing EPS12.632 TWD
Price / book3.50
Dividend yield0.00%
Market cap53.88B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Bora Pharmaceuticals (6472.TW)'s next earnings date?

Bora Pharmaceuticals is next scheduled to report on 2026-08-18, with a consensus EPS estimate of 5.05 TWD and revenue estimate of 5.48B.

Did 6472.TW beat earnings last quarter?

In its 2026-03-11 report, 6472.TW posted EPS of 2.65 TWD versus a 7.49 TWD estimate — a miss of 64.6%.

What is 6472.TW's earnings track record?

Over the last 4 reported quarters with consensus data, 6472.TW beat estimates 0 times (0%).

What is 6472.TW's current P/E ratio and EPS?

6472.TW trades at a trailing P/E of 31.18 on trailing EPS of 12.63159714038809 TWD.

What do analysts rate 6472.TW?

6472.TW has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.